Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Report ID | 111239 |
Drug Identification Number | 02439379 |
Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
Common or Proper name | Ropivacaine Hydrochloride Injection, USP, 2 mg/mL freeflex® Bag 100 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | EPIDURAL INFILTRATION INFILTRATION EPIDURAL |
Packaging size | 100 mL |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-04-01 |
Actual start date | 2020-04-01 |
Estimated end date | 2020-04-20 |
Actual end date | 2020-04-24 |
Shortage status | Resolved |
Updated date | 2020-04-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-04-25 | English | Compare |
v4 | 2020-04-22 | French | Compare |
v3 | 2020-04-22 | English | Compare |
v2 | 2020-04-07 | French | Compare |
v1 | 2020-04-07 | English | Compare |
Showing 1 to 5 of 5